bioavailability of glp-1 treatments Transforming obesity: The advancement multi-receptor drugs: Cell PDB-101: Molecule of the Month:

GLP-1 itself is a hormone produced by L-cells in the human intestine

APPLICATION Simple trans-dermotherapy: Simple topical application, topical application with massage, topical application post-peeling, application with post-peeling massage, etc

Broader Implications The rise of GLP-1 medications is intersecting with global public health efforts against diabetes and obesity

Multi-locus genome-wide association analysis supports the role of glutamatergic synaptic transmission in the etiology of major depressive disorder

GLP-1 might be more important for total appetite control, but GIPs contribution to the overall weight loss magnitude is clearly significant